The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Showing 1-20 of 52 articles
Percutaneous treatment options for acute pulmonary embolism: a clinical consensus statement by the ESC Working Group on pulmonary circulation and right ventricular function and the European Association of Percutaneous Cardiovascular Interventions
Pruszczyk P,
Klok F,
Kucher N,
Roik M,
Meneveau N,
Sharp A,
Nielsen-Kudsk J,
Obradović S,
Barco S,
Giannini F,
Stefanini G,
Tarantini G,
Konstantinides S,
Dudek D
September 13, 2022 | 10.4244/EIJ-D-22-00246
Ticagrelor with and without aspirin in patients with a prior coronary artery bypass graft undergoing percutaneous coronary intervention: the TWILIGHT-CABG study
Sardella G,
Beerkens F,
Dangas G,
Cao D,
Baber U,
Sartori S,
Cohen D,
Briguori C,
Gil R,
Nicolas J,
Zhang Z,
Dudek D,
Kunadian V,
Kornowski R,
Weisz G,
Claessen B,
Marx S,
Escaned J,
Huber K,
Collier T,
Moliterno D,
Ohman EM,
Krucoff M,
Kastrati A,
Steg PG,
Angiolillo D,
Mehta SR,
Shlofmitz R,
Sharma S,
Pocock S,
Gibson CM,
Mehran R
August 18, 2022 | 10.4244/EIJ-D-22-00319
Coronary access techniques following ACURATE neo2 implantation in surgical bioprosthesis
June 16, 2022 | 10.4244/EIJ-D-22-00149
Definitions and Standardized Endpoints for Treatment of Coronary Bifurcations
Lunardi M,
Louvard Y,
Lefèvre T,
Stankovic G,
Burzotta F,
Kassab G,
Lassen J,
Darremont O,
Garg S,
Koo B,
Holm N,
Johnson T,
Pan M,
Chatzizisis Y,
Banning A,
Chieffo A,
Dudek D,
Hildick-Smith D,
Garot J,
Henry T,
Dangas G,
Stone G,
Krucoff M,
Cutlip D,
Mehran R,
Wijns W,
Sharif F,
Serruys P,
Onuma Y
May 18, 2022 | 10.4244/EIJ-E-22-00018
Safety and efficacy of ticagrelor monotherapy according to drug-eluting stent type: the TWILIGHT-STENT study
Dangas G,
Baber U,
Sharma S,
Giustino G,
Sartori S,
Nicolas J,
Goel R,
Mehta SR,
Cohen D,
Angiolillo D,
Zhang Z,
Camaj A,
Cao D,
Briguori C,
Dudek D,
Escaned J,
Huber K,
Collier T,
Kornowski R,
Kunadian V,
Moliterno D,
Ohman EM,
Weisz G,
Gil R,
Krucoff M,
Kaul U,
Oldroyd K,
Sardella G,
Shlofmitz R,
Witzenbichler B,
Kastrati A,
Han Y,
Steg PG,
Pocock S,
Gibson CM,
Mehran R
March 18, 2022 | 10.4244/EIJ-D-21-00721
Robotics, imaging, and artificial intelligence in the catheterisation laboratory
September 20, 2021 | 10.4244/EIJ-D-21-00145
European position paper on the management of patients with patent foramen ovale. Part II - Decompression sickness, migraine, arterial deoxygenation syndromes and select high-risk clinical conditions
Pristipino C,
Germonpré P,
Toni D,
Sievert H,
Meier B,
D'Ascenzo F,
Berti S,
Onorato E,
Bedogni F,
Mas J,
Scacciatella P,
Hildick-Smith D,
Gaita F,
Kyrle P,
Thomson J,
Derumeaux G,
Sibbing D,
Chessa M,
Hornung M,
Zamorano J,
Dudek D
August 6, 2021 | 10.4244/EIJ-D-20-00785
Joint EAPCI/ACVC expert consensus document on percutaneous ventricular assist devices
Chieffo A,
Dudek D,
Hassager C,
Combes A,
Gramegna M,
Halvorsen S,
Huber K,
Kunadian V,
Maly J,
Møller J,
Pappalardo F,
Tarantini G,
Tavazzi G,
Thiele H,
Vandenbriele C,
Van Mieghem N,
Vranckx P,
Werner N,
Price S
July 20, 2021 | 10.4244/EIJY21M05_01
EAPCI Core Curriculum for Percutaneous Cardiovascular Interventions (2020): Committee for Education and Training European Association of Percutaneous Cardiovascular Interventions (EAPCI). A branch of the European Society of Cardiology.
Van Belle E,
Teles R,
Pyxaras S,
Kalpak O,
Johnson T,
Barbash I,
De Luca G,
Kostov J,
Parma R,
Vincent F,
Brugaletta S,
Debry N,
Toth G,
Ghazzal Z,
Deharo P,
Milasinovic D,
Kaspar K,
Saia F,
Mauri Ferre J,
Kammler J,
Muir D,
O'Connor S,
Mehilli J,
Thiele H,
Weilenmann D,
Witt N,
Joshi F,
Kharbanda R,
Piroth Z,
Wojakowski W,
Geppert A,
Di Gioia G,
Pires-Morais G,
Petronio A,
Estévez-Loureiro R,
Ruzsa Z,
Kefer J,
Kunadian V,
Van Mieghem N,
Windecker S,
Baumbach A,
Haude M,
Dudek D
May 16, 2021 | 10.4244/EIJ-D-18-00448
Performing elective cardiac invasive procedures during the COVID-19 outbreak: a position statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
Chieffo A,
Tarantini G,
Naber C,
Barbato E,
Roffi M,
Stefanini G,
Buchanan G,
Buszman P,
Moreno R,
Zawiślak B,
Cayla G,
Danenberg H,
Da Silveira J,
Nef H,
James S,
Mauri Ferre J,
Voskuil M,
Witt N,
Windecker S,
Baumbach A,
Dudek D
February 19, 2021 | 10.4244/EIJ-D-20-01291
Bioresorbable scaffolds versus everolimus-eluting metallic stents: five-year clinical outcomes of the randomised ABSORB II trial
Onuma Y,
Chevalier B,
Ono M,
Cequier A,
Dudek D,
Haude M,
Carrié D,
Sabaté M,
Windecker S,
Rapoza R,
West N,
Reith S,
de Sousa Almeida M,
Campo G,
Iñiguez A,
Serruys P
December 4, 2020 | 10.4244/EIJ-D-20-00024
Bioresorbable vascular scaffold versus metallic drug-eluting stent in patients at high risk of restenosis: the COMPARE-ABSORB randomised clinical trial
Smits P,
Chang C,
Chevalier B,
West N,
Gori T,
Barbato E,
Tarantini G,
Kocka V,
Achenbach S,
Dudek D,
Escaned J,
Wlodarczak A,
Abdel-Wahab M,
Esposito G,
Tijssen J,
Morice M,
Onuma Y,
van Geuns R
October 23, 2020 | 10.4244/EIJ-D-19-01079
A call for standardisation of vascular access in transcatheter cardiovascular procedures
October 9, 2020 | 10.4244/EIJV16I9A130
EAPCI Position Statement on Invasive Management of Acute Coronary Syndromes during the COVID-19 pandemic
Chieffo A,
Stefanini G,
Price S,
Barbato E,
Tarantini G,
Karam N,
Moreno R,
Buchanan G,
Gilard M,
Halvorsen S,
Huber K,
James S,
Neumann F,
Möllmann H,
Roffi M,
Tavazzi G,
Mauri Ferre J,
Windecker S,
Dudek D,
Baumbach A
June 25, 2020 | 10.4244/EIJY20M05_01
Impact of the COVID-19 pandemic on interventional cardiology practice: results of the EAPCI survey
June 25, 2020 | 10.4244/EIJ-D-20-00528
Evolving paradigms in valvular heart disease: where should guidelines move?
November 15, 2019 | 10.4244/EIJ-D-19-00818
Five-year safety and performance data of a novel third-generation novolimus-eluting bioresorbable scaffold in single de novo lesions
Verheye S,
Costa R,
Schofer J,
Ormiston J,
Maeng M,
Dudek D,
Skurk C,
Botelho R,
Costa J,
Chamié D,
Abizaid An,
Boersma E,
Abizaid A
October 18, 2019 | 10.4244/EIJ-D-18-00292
Clinical outcomes of state-of-the-art percutaneous coronary revascularisation in patients with three-vessel disease: two-year follow-up of the SYNTAX II study
Serruys P,
Farooq V,
Banning A,
Escaned J,
Wykrzykowska JJ,
Piek JJ,
Dudek D,
Ochala A,
Hildick-Smith D,
Goicolea J,
Iñiguez A,
Buszman P,
Modolo R,
Katagiri Y,
Kogame N,
Onuma Y
June 12, 2019 | 10.4244/EIJ-D-18-00980
Latest news
AHEAD OF PRINT
COMBINE OCT–FFR study extended follow-up
FREE ARTICLE - Enrico Fabris et al
September 28, 2022
NEW ISSUE
A state-of-the-art on CTO recanalisation; timing of coronary angiography in NSTE-ACS; an expert consensus on the use of IVUS in peripheral interventions, and more
September 20, 2022
AHEAD OF PRINT
The UZ Clear study
FREE ARTICLE - Bert Vandeloo et al
September 23, 2022
AHEAD OF PRINT
Subanalysis of SCOPE 2 – pacemaker and LBBB
FREE ARTICLE - Costanza Pellegrini et al
September 21, 2022
AHEAD OF PRINT TCT
Early Alirocumab treatment in STEMI
FREE ARTICLE - Shamir R. Mehta et al
September 19, 2022
AHEAD OF PRINT TCT
Timing of Bioprosthetic valve fracture in transcatheter valvein- valve intervention: impact on valve durability and leaflet integrity
FREE ARTICLE - David Meier et al
September 18, 2022
AHEAD OF PRINT TCT
Acute Outcomes for the Full US Cohort of the FLASH Mechanical Thrombectomy Registry in Pulmonary Embolism
FREE ARTICLE - Catalin Toma et al
September 18, 2022